Getting Started on VANRAFIA
First ETA receptor antagonist in IgAN without a REMS program
Use of VANRAFIA is contraindicated in patients who are pregnant and patients with hypersensitivity. Serious warnings associated with VANRAFIA include embryo-fetal toxicity, hepatotoxicity, fluid retention, and decreased sperm counts. Most common adverse reactions (incidence ≥5%) were peripheral edema and anemia. Please see additional Important Safety Information throughout.
Prescribe VANRAFIA two different ways
SUBMIT Rx THROUGH NOVARTIS PATIENT SUPPORT™
 |
Submit the Start Form to Novartis Patient Support by downloading and faxing to 1-877-6VANRAF (1-877-682-6723) or electronically via the CoverMyMeds portal at www.CoverMyMeds.health ↗
Phone: 1-844-4VANRAF (1-844-482-6723)
Monday through Friday, 8:00 ᴀᴍ to 8:00 ᴘᴍ ET, excluding holidays
SUBMIT Rx THROUGH ONE OF THE TWO SPECIALTY PHARMACIES
 |
|
CareMed*
Website: caremedsp.com ↗
Phone: 1-877-227-3405
Fax: 1-877-542-2731
Biologics by McKesson
Website: biologics.mckesson.com ↗
Phone: 1-800-850-4306
Fax: 1-800-823-4506
Either of the two specialty pharmacies can help you access VANRAFIA. Ensure your patient is aware which specialty pharmacy will dispense their medication.
Novartis does not recommend or require the use of any particular pharmacy.
Inform your patient that the specialty pharmacy will reach out or call them directly and a confirmation of scheduling between patient and specialty pharmacy is required before VANRAFIA can be delivered.
*CareMed is a subsidiary of Onco360®.
Help your patients start and stay on VANRAFIA
See the resources available for download